Presenilin mutations in Alzheimer's disease: molecular models suggest a potential functional locus

Author： Murgolo N.J.   Brown J.E.   Bayne M.L.   Strader C.D.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.17, Iss.11, 1996-11, pp. : 389-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 1, 2013-02 ,pp. : 62-69

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential in Alzheimer Disease

By  

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1605-1610

Bentham Science Publishers

Access to resources Recommend Favorite

A Survey of Peptides with Effective Therapeutic Potential in Alzheimer’s Disease Rodent Models or in Human Clinical Studies

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 5, 2012-05 ,pp. : 388-398

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular and Biochemical Features in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4389-4408

Bentham Science Publishers

Access to resources Recommend Favorite

Introduction: Strategies, Molecular Targets and Animal Models Useful for Developing Therapies for Alzheimer's Disease

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 1, 2005-03 ,pp. : 1-3

Bentham Science Publishers

Access to resources Recommend Favorite